Boston Scientific’s $14.5B Penumbra Deal Leads a Busy Day for BSX, VZ, GS, MS and ASTS
Boston Scientific agreed to buy Penumbra for about $14.5 billion, sending Penumbra shares up more than 12%. Verizon offered $20 credits after a 10-hour wireless outage drew federal scrutiny. Goldman Sachs and Morgan Stanley reported higher quarterly profits on increased dealmaking and trading.